Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Califf Nomination May Show Confidence In His Bipartisan Appeal

This article was originally published in The Pink Sheet Daily

Executive Summary

After seven months as deputy commissioner for medical products and tobacco, Robert Califf tapped to be FDA Commissioner.


Related Content

FDA Head Califf Says He Won't Need To Fight To Stay
Califf Says He Won't Need To Fight To Stay
Califf Says He Doesn't Need To Fight To Stay
Opioids Can't Stop Califf Confirmation
Califf Nomination Suffers 'Pile On': What Can FDA Do To Break Logjam?
PDUFA Budgeting: What Will Get Added, Subtracted – Or Multiplied By Cures?
Oral History Of Drug Development: FDA’s Califf Wants Woodcock, Temple To Share Their Stories
Podcast: FDA's Califf Talks About Combo Product Reform, Commish Prospects
FDA Staying The Course Under Ostroff; Hamburg’s Concerns Will Remain Focus
FDA Lands Duke’s Califf As Top Deputy, Potential Next Commissioner





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts